inhaled beta-agonists MIGHT increase the risk of heart attacks in COPD patients
September 2002
There's new concern that inhaled beta-agonists MIGHT increase the risk of heart attacks in COPD patients.
Many COPD patients get salbutamol or another inhaled beta-agonist to improve breathing.
But new evidence suggests a higher risk of unstable angina and heart attacks in patients using inhaled beta-agonists.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive